Altre lingue Poltreg S.A.

Azioni

PTG

PLPLTRG00038

Mercato chiuso - Warsaw S.E. Altri mercati azionari 18:03:15 28/06/2024			Variaz. 5gg	Var. 1 gen.
50 ^PLN	+3,73%		+5,49%	+0,40%

24/06	La terapia con cellule Treg per il diabete di tipo-1 di PolTREG, PTG-007, dimostra sicurezza ed efficacia a lungo termine, fino a 12 anni.	CI
23/05	Poltreg S.A. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for up to 12 years	24/06
PolTREG?s Type-1 Diabetes Treg Cell Therapy PTG-007 Demonstrates Long-Term Safety and Efficacy for Up to 12 Years	24/06
Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Poltreg S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	18/04
PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients treated with its Treg therapy in combination with rituximab	04/04
PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland	11/03
Poltreg S.A. Receives CGMP Certification to Produce Cell Therapies At Its State-Of-The-Art Manufacturing Site in Poland	11/03
PolTREG appoints Dan Shelly as Chief Business Development Officer	21/02
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapy	30/01
PolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 Diabetes	16/01
Poltreg S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Poltreg S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/09/23
Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/05/23
Poltreg S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23
Poltreg S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/11/22
Poltreg S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	31/08/22
Poltreg S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/05/22
Poltreg S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22
Poltreg S.A. has completed an IPO in the amount of PLN 125.086575 million.	08/11/21
Poltreg S.A. has filed an IPO in the amount of PLN 130 million.	14/10/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Poltreg S.A.

Azioni

PTG

PLPLTRG00038

Altre lingue

Filtri